Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars M Wagner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Sarcoma Research|September 1, 2015
Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?Lars M Wagner
Oncotargets and Therapy|August 8, 2015
Profile of veliparib and its potential in the treatment of solid tumorsLars M Wagner
Oncotargets and Therapy|April 27, 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumorsLars M Wagner, Val R Adams
Journal of Cellular Biochemistry|March 12, 2009
New therapeutic targets for the treatment of high-risk neuroblastomaLars M Wagner, Mary K Danks
Translational Andrology and Urology|November 19, 2020
Imaging of childhood urologic cancers: current approaches and new advancesJoseph T Davis, Lars M Wagner
Cancers|July 24, 2021
Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid TumorsAndrew J Bellantoni, Lars M Wagner
Pediatric Blood & Cancer|June 21, 2018
Immunotherapy for osteosarcoma: Where do we go from here?Mary F Wedekind, Lars M Wagner, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|November 24, 2016
Early Lymphocyte Recovery and Outcome in OsteosarcomaLynn Lee, Lin Fei, Jennifer Pope, et al.
Pediatric Blood & Cancer|April 24, 2021
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcomaMarissa A Just, David Van Mater, Lars M Wagner
Sarcoma|May 3, 2012
Assessment of minimal residual disease in ewing sarcomaLars M Wagner, Teresa A Smolarek, Janos Sumegi, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Sarcoma Research|September 1, 2015
Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?Lars M Wagner
Oncotargets and Therapy|August 8, 2015
Profile of veliparib and its potential in the treatment of solid tumorsLars M Wagner
Oncotargets and Therapy|April 27, 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumorsLars M Wagner, Val R Adams
Journal of Cellular Biochemistry|March 12, 2009
New therapeutic targets for the treatment of high-risk neuroblastomaLars M Wagner, Mary K Danks
Translational Andrology and Urology|November 19, 2020
Imaging of childhood urologic cancers: current approaches and new advancesJoseph T Davis, Lars M Wagner
Cancers|July 24, 2021
Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid TumorsAndrew J Bellantoni, Lars M Wagner
Pediatric Blood & Cancer|June 21, 2018
Immunotherapy for osteosarcoma: Where do we go from here?Mary F Wedekind, Lars M Wagner, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|November 24, 2016
Early Lymphocyte Recovery and Outcome in OsteosarcomaLynn Lee, Lin Fei, Jennifer Pope, et al.
Pediatric Blood & Cancer|April 24, 2021
Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcomaMarissa A Just, David Van Mater, Lars M Wagner
Sarcoma|May 3, 2012
Assessment of minimal residual disease in ewing sarcomaLars M Wagner, Teresa A Smolarek, Janos Sumegi, et al.
Pageof 5